Douglas Matthew Brown - 23 Nov 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Strategy Officer
Signature
/s/ Doug M Brown
Issuer symbol
NEO
Transactions as of
23 Nov 2021
Net transactions value
-$3,696,000
Form type
4
Filing time
26 Nov 2021, 15:14:57 UTC
Next filing
30 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Sale $1,239,654 -33,333 -30% $37.19 78,311 23 Nov 2021 Direct F1
transaction NEO Common Stock Sale $1,227,988 -33,333 -43% $36.84 44,978 24 Nov 2021 Direct F1
transaction NEO Common Stock Sale $1,228,358 -33,334 -74% $36.85 11,644 26 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 45,017 23 Nov 2021 Common Stock 45,017 $28.33 Direct F2
holding NEO Stock Option (Right to Buy) 26,378 23 Nov 2021 Common Stock 26,378 $53.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.